Terminating prolonged refractory status epilepticus using ketamine

Cheng Yang Hsieh, Pi Shan Sung, Jing Jane Tsai, Chin Wei Huang

研究成果: Article同行評審

49 引文 斯高帕斯(Scopus)

摘要

Refractory status epilepticus (RSE) is an emergent and difficult neurologic problem that is not uncommon in clinical practice. In this report, we describe a 23-year-old man whose RSE was refractory to standard antiepileptic drugs and barbiturates; it was successfully terminated only with intravenous ketamine. In this report, we evaluated and discuss the clinical and electroencephalographic effects under ketamine. This case and the rare cases of ketamine experience in RSE reported in the literature show that ketamine is potentially effective to use when treating patients with RSE. Further clinical trials are warranted, however.

原文English
頁(從 - 到)165-167
頁數3
期刊Clinical Neuropharmacology
33
發行號3
DOIs
出版狀態Published - 2010 5月

All Science Journal Classification (ASJC) codes

  • 藥理
  • 神經病學(臨床)
  • 藥學(醫學)

指紋

深入研究「Terminating prolonged refractory status epilepticus using ketamine」主題。共同形成了獨特的指紋。

引用此